Lotte N. Husemoen

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 73 publications

Incorporating estimands into meta-analyses of clinical trials.

Incorporating estimands into meta-analyses of clinical trials.

Journal: Research synthesis methods

Published: July 30, 2026

Prevalence and characteristics of adults with atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation in the USA.

Prevalence and characteristics of adults with atherosclerotic cardiovascular disease, chronic kidney disease, and systemic inflammation in the USA.

Journal: American heart journal plus : cardiology research and practice

Published: September 24, 2025

Glycemic Control and Risk of Congenital Malformations in Women With Type 1 Diabetes.

Glycemic Control and Risk of Congenital Malformations in Women With Type 1 Diabetes.

Journal: Obstetrics and gynecology

Published: March 14, 2024

Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort.

Fetal Overgrowth and Preterm Delivery in Women With Type 1 Diabetes Using Insulin Pumps or Multiple Daily Injections: A Post Hoc Analysis of the EVOLVE Study Cohort.

Journal: Diabetes care

Published: July 11, 2023

Safety and glycemic control with insulin degludec use in clinical practice: results from a 3-year Japanese post-marketing surveillance study.

Safety and glycemic control with insulin degludec use in clinical practice: results from a 3-year Japanese post-marketing surveillance study.

Journal: Diabetology international

Published: April 21, 2023

Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.

Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.

Journal: Circulation

Published: March 06, 2023

Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.

Congenital malformations among offspring of women with type 1 diabetes who use insulin pumps: a prospective cohort study.

Journal: Diabetologia

Published: May 25, 2022

Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study.

Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: July 09, 2021

Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study.

Characteristics of pregnant women with diabetes using injectable glucose-lowering drugs in the EVOLVE study.

Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Published: June 29, 2021

Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study.

Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study.

Journal: Diabetes care

Published: February 26, 2021

All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK.

All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: December 10, 2020

Understanding Patients' Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market.

Understanding Patients' Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market.

Journal: PharmacoEconomics - open

Published: December 10, 2020

Showing 1-12 of 73

Last Updated: 09/26/2026